Project description
Accelerating drug development
The world of drug discovery is exciting but very challenging. Effective drug development starts with cell-based assays research, which involves creating test systems with which to test the efficacy and toxicity of compounds. This makes physiological and predictive pre-clinical in vitro assays essential for new medicines to hit the market. To facilitate the process, the EU-funded ARON project has developed a so-called assay-ready organ network, described as the most advanced modular in vitro assay platform that will set a new standard for a wide range of cell-based, pre-clinical testing. It will shift the organ-on-a-chip technology from a late-stage, luxury service to routinely used ready-to-use assays. Overall, the project aims to reduce costs, time to market and animal testing.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
8952 Schlieren
Switzerland
See on map